Back to Search
CHARLES WYKOFF, MD, PHD
Ophthalmology Physician
NPI: 1124237300IndividualAccepts Medicare
Specialties, Licenses & Credentials
Retina Specialist (Ophthalmology) Physician
Ophthalmology — Retina Specialist
Code: 207WX0107X
N9336(TX)
Ophthalmology PhysicianPrimary
Ophthalmology
Code: 207W00000X
N9336(TX)
Education
HARVARD MEDICAL SCHOOL
Class of 2005
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Long-Term Efficacy & Safety of Aflibercept IVT for the Treatment of DME in Subjects Who Completed the VISTA-DME Trial
NCT02299336COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Widefield Angiography Guided Targeted-retinal Photocoagulation Combined With Anti VEgf Intravitreal Injections for the Treatment of Ischemic Central Retinal Vein Occlusion, Hemi Retinal Vein Occlusion, and Branch Retinal Vein Occlusion
NCT01710839COMPLETEDPHASE4PRINCIPAL_INVESTIGATOR
Research & Publications (20)
RETINAL VASCULAR BED AREA IN EYES WITH RETINAL VEIN OCCLUSION ON ULTRA-WIDEFIELD FLUORESCEIN ANGIOGRAPHY: WAVE Study.
PMID 35976232·Retina·2022
4-observational
Long-term outcomes with as-needed aflibercept in diabetic macular oedema: 2-year outcomes of the ENDURANCE extension study.
PMID 28814412·Br J Ophthalmol·2018
3-trial
Peripheral Laser for Recalcitrant Macular Edema Owing to Retinal Vein Occlusion: The WAVE Trial.
PMID 28318636·Ophthalmology·2017
3-trial
Sustained benefits from ranibizumab for macular edema following central retinal vein occlusion: twelve-month outcomes of a phase III study.
PMID 21715011·Ophthalmology·2011
3-trial
Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.
PMID 20427088·Ophthalmology·2010
4-observational
Ranibizumab for macular edema following central retinal vein occlusion: six-month primary end point results of a phase III study.
PMID 20381871·Ophthalmology·2010
3-trial
Primary intravitreal bevacizumab for diffuse diabetic macular edema: the Pan-American Collaborative Retina Study Group at 24 months.
PMID 19545900·Ophthalmology·2009
4-observational
Projection of diabetic retinopathy and other major eye diseases among people with diabetes mellitus: United States, 2005-2050.
PMID 19064858·Arch Ophthalmol·2008
8-other
Intravitreal steroids for macular edema in diabetes.
PMID 18254088·Cochrane Database Syst Rev·2008
1-meta
Vascular endothelial growth factor is a critical stimulus for diabetic macular edema.
PMID 17046701·Am J Ophthalmol·2006
3-trial
Correlation of increased vascular endothelial growth factor with neovascularization and permeability in ischemic central vein occlusion.
PMID 12470137·Arch Ophthalmol·2002
8-other
VEGF: an update on biological and therapeutic aspects.
PMID 11102799·Curr Opin Biotechnol·2000
6-review
Atypical teratoid/rhabdoid tumor arising from the third cranial nerve.
PMID 18769285·J Neuroophthalmol·2008
5-case
Exogenous fungal endophthalmitis: microbiology and clinical outcomes.
PMID 18486220·Ophthalmology·2008
8-other
Myopic laser in situ keratomileusis in eyes with thick corneas.
PMID 16765817·J Cataract Refract Surg·2006
8-other
Gene array of VHL mutation and hypoxia shows novel hypoxia-induced genes and that cyclin D1 is a VHL target gene.
PMID 15026807·Br J Cancer·2004
8-other
The hypoxia-regulated transcription factor DEC1 (Stra13, SHARP-2) and its expression in human tissues and tumours.
PMID 15221940·J Pathol·2004
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4460 BISSONNET ST STE 200
BELLAIRE, TX 77401 - Phone
- (713) 524-3434
Quick Facts
- NPI
- 1124237300
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Clinical Trials
- 2
- Publications
- 20
Are you this provider?
Claim Your Profile